AJU IB Investment Co., Ltd. Long-Term Concentrated

Location: Seoul, Korea, Republic of

CIK: 0001710065 · Show all filings

Period: Q4 2024 (← Previous) (Next →)

Filing Date: Apr 8, 2025

Total Value: $103M (100.0% shares, 0.0% debt)

Holdings (8)

ACLX ARCELLX INC 78.2%

Value $80.34M Shares 1,047,557 Est. Cost $16.72 Unrealized +416.7%

KYMR KYMERA THERAPEUTICS INC 17.9%

Value $18.39M Shares 457,059 Est. Cost $48.78 Unrealized -7.4%

SEER SEER INC 1.8%

Value $1.886M Shares 816,375 Est. Cost $63.62 Unrealized -96.6%

— RALLYBIO CORP 0.7%

Value $724K Shares 754,678 Est. Cost $9.54 Unrealized —

XLO XILIO THERAPEUTICS INC 0.6%

Value $638K Shares 667,742 Est. Cost $17.03 Unrealized -94.2%

— SUTRO BIOPHARMA INC 0.3%

Value $322K Shares 175,000 Est. Cost $21.71 Unrealized —

CARM CARISMA THERAPEUTICS INC 0.3%

Value $301K Shares 718,332 Est. Cost $0.82 Unrealized 0.0%

— RAPT THERAPEUTICS INC 0.2%

Value $157K Shares 99,503 Est. Cost $19.75 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ACLX	ARCELLX INC	1,047,557	$80.34M	78.2%	$16.72	+416.7%	COMMON STOCK	03940C100
KYMR	KYMERA THERAPEUTICS INC	457,059	$18.39M	17.9%	$48.78	-7.4%	COM	501575104
SEER	SEER INC	816,375	$1.886M	1.8%	$63.62	-96.6%	COM CL A	81578P106
—	RALLYBIO CORP	754,678	$724K	0.7%	$9.54	—	COM	75120L100
XLO	XILIO THERAPEUTICS INC	667,742	$638K	0.6%	$17.03	-94.2%	COM	98422T100
—	SUTRO BIOPHARMA INC	175,000	$322K	0.3%	$21.71	—	COM	869367102
CARM	CARISMA THERAPEUTICS INC	718,332	$301K	0.3%	$0.82	0.0%	COM	14216R101
—	RAPT THERAPEUTICS INC	99,503	$157K	0.2%	$19.75	—	COM	75382E109